Biohaven Ltd. financial data

Symbol
BHVN on NYSE
Location
New Haven, CT
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 02 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 300% % -11%
Debt-to-equity 336% % 581%
Return On Equity -689% % -190%
Return On Assets -158% % 0.72%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 150,417,084 shares 47%
Common Stock, Shares, Outstanding 132,775,113 shares 31%
Entity Public Float $1,044,000,000 USD -53%
Common Stock, Value, Issued $1,934,276,000 USD 17%
Weighted Average Number of Shares Outstanding, Basic 107,624,885 shares 18%
Weighted Average Number of Shares Outstanding, Diluted 107,624,885 shares 18%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $635,065,000 USD -20%
General and Administrative Expense $110,313,000 USD 24%
Costs and Expenses $745,378,000 USD -16%
Operating Income (Loss) $745,378,000 USD 16%
Nonoperating Income (Expense) $7,998,000 USD -80%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $737,380,000 USD 13%
Income Tax Expense (Benefit) $1,442,000 USD 96%
Net Income (Loss) Attributable to Parent $738,822,000 USD 13%
Earnings Per Share, Basic -6.86 USD/shares 26%
Earnings Per Share, Diluted -6.86 USD/shares 26%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $229,957,000 USD 132%
Marketable Securities, Current $89,180,000 USD -77%
Other Assets, Current $2,170,000 USD -30%
Assets, Current $368,329,000 USD -32%
Property, Plant and Equipment, Net $15,964,000 USD -7.8%
Operating Lease, Right-of-Use Asset $45,058,000 USD 24%
Intangible Assets, Net (Excluding Goodwill) $18,400,000 USD 0%
Goodwill $1,390,000 USD 0%
Other Assets, Noncurrent $47,364,000 USD 20%
Assets $451,447,000 USD -27%
Accounts Payable, Current $11,643,000 USD -35%
Employee-related Liabilities, Current $16,781,000 USD 10797%
Accrued Liabilities, Current $104,291,000 USD 103%
Liabilities, Current $115,934,000 USD -25%
Operating Lease, Liability, Noncurrent $39,958,000 USD 22%
Other Liabilities, Noncurrent $4,583,000 USD -1.7%
Liabilities $399,375,000 USD 108%
Accumulated Other Comprehensive Income (Loss), Net of Tax $8,348,000 USD 10467%
Retained Earnings (Accumulated Deficit) $2,084,536,000 USD -55%
Stockholders' Equity Attributable to Parent $52,072,000 USD -88%
Liabilities and Equity $451,447,000 USD -27%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $165,124,000 USD -61%
Net Cash Provided by (Used in) Financing Activities $369,000 USD -89%
Net Cash Provided by (Used in) Investing Activities $164,879,000 USD 384%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 132,775,113 shares 31%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $147,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $232,779,000 USD 127%
Deferred Tax Assets, Valuation Allowance $313,353,000 USD 3.2%
Operating Lease, Liability $45,714,000 USD 25%
Depreciation $4,140,000 USD 5.5%
Payments to Acquire Property, Plant, and Equipment $461,000 USD 4.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $730,553,000 USD 14%
Lessee, Operating Lease, Liability, to be Paid $63,075,000 USD 28%
Operating Lease, Liability, Current $5,756,000 USD 51%
Lessee, Operating Lease, Liability, to be Paid, Year Two $9,239,000 USD 49%
Lessee, Operating Lease, Liability, to be Paid, Year One $9,138,000 USD 49%
Operating Lease, Weighted Average Discount Rate, Percent 0.088 pure 16%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $17,361,000 USD 36%
Lessee, Operating Lease, Liability, to be Paid, Year Three $7,501,000 USD 28%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $2,600,000 USD 13%
Lessee, Operating Lease, Liability, to be Paid, Year Four $6,950,000 USD 31%
Additional Paid in Capital $193,984,000 USD 73%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $2,246,000 USD 55%
Deferred Tax Assets, Net of Valuation Allowance $7,838,000 USD -6.9%